{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:18:21Z","timestamp":1791087501893,"version":"4.1.0"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:p>OBJECTIVES. The goals were to determine the prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization in patients with atopic dermatitis and to determine whether suppression of S aureus growth with sodium hypochlorite (bleach) baths and intranasal mupirocin treatment improves eczema severity.<\/jats:p>\n                  <jats:p>METHODS. A randomized, investigator-blinded, placebo-controlled study was conducted with 31 patients, 6 months to 17 years of age, with moderate to severe atopic dermatitis and clinical signs of secondary bacterial infections. All patients received orally administered cephalexin for 14 days and were assigned randomly to receive intranasal mupirocin ointment treatment and sodium hypochlorite (bleach) baths (treatment arm) or intranasal petrolatum ointment treatment and plain water baths (placebo arm) for 3 months. The primary outcome measure was the Eczema Area and Severity Index score.<\/jats:p>\n                  <jats:p>RESULTS. The prevalence of community-acquired methicillin-resistant S aureus in our study (7.4% of our S aureus\u2013positive skin cultures and 4% of our S aureus\u2013positive nasal cultures) was much lower than that in the general population with cultures at Children's Memorial Hospital (75%\u201385%). Patients in the group that received both the dilute bleach baths and intranasal mupirocin treatment showed significantly greater mean reductions from baseline in Eczema Area and Severity Index scores, compared with the placebo group, at the 1-month and 3-month visits. The mean Eczema Area and Severity Index scores for the head and neck did not decrease for patients in the treatment group, whereas scores for other body sites (submerged in the dilute bleach baths) decreased at 1 and 3 months, in comparison with placebo-treated patients.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Chronic use of dilute bleach baths with intermittent intranasal application of mupirocin ointment decreased the clinical severity of atopic dermatitis in patients with clinical signs of secondary bacterial infections. Patients with atopic dermatitis do not seem to have increased susceptibility to infection or colonization with resistant strains of S aureus.<\/jats:p>","DOI":"10.1542\/peds.2008-2217","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T09:17:09Z","timestamp":1240823829000},"page":"e808-e814","source":"Crossref","is-referenced-by-count":421,"title":["Treatment of\n                    <i>Staphylococcus aureus<\/i>\n                    Colonization in Atopic Dermatitis Decreases Disease Severity"],"prefix":"10.1542","volume":"123","author":[{"given":"Jennifer T.","family":"Huang","sequence":"first","affiliation":[{"name":"Departments of Dermatology"},{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Abrams","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"},{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brook","family":"Tlougan","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"},{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Rademaker","sequence":"additional","affiliation":[{"name":"Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"},{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"key":"2021120902384819000_R1","doi-asserted-by":"crossref","unstructured":"Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy.\u20082004;59(suppl 78):86\u201392","DOI":"10.1111\/j.1398-9995.2004.00569.x"},{"key":"2021120902384819000_R2","doi-asserted-by":"crossref","unstructured":"Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol.\u20082004;4(5):373\u2013378","DOI":"10.1097\/00130832-200410000-00008"},{"key":"2021120902384819000_R3","doi-asserted-by":"crossref","unstructured":"Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol.\u20081974;90(5):525\u2013530","DOI":"10.1111\/j.1365-2133.1974.tb06447.x"},{"key":"2021120902384819000_R4","doi-asserted-by":"crossref","unstructured":"Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr.\u20082005;17(1):67\u201370","DOI":"10.1097\/01.mop.0000147906.30720.4d"},{"key":"2021120902384819000_R5","doi-asserted-by":"crossref","unstructured":"Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis.\u20082003;37(7):933\u2013938","DOI":"10.1086\/377735"},{"key":"2021120902384819000_R6","doi-asserted-by":"crossref","unstructured":"Hanifin JM, Thurston M, Omoto M, et al. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol.\u20082001;10(1):11\u201318","DOI":"10.1034\/j.1600-0625.2001.100102.x"},{"key":"2021120902384819000_R7","doi-asserted-by":"crossref","unstructured":"Wolff K, Fleming C, Hanifin J, et al. Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. Br J Dermatol.\u20082005;152(6):1296\u20131303","DOI":"10.1111\/j.1365-2133.2005.06674.x"},{"key":"2021120902384819000_R8","doi-asserted-by":"crossref","unstructured":"Higaki S, Morohasi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol.\u20081999;38(4):265\u2013269","DOI":"10.1046\/j.1365-4362.1999.00686.x"},{"key":"2021120902384819000_R9","doi-asserted-by":"crossref","unstructured":"Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol.\u20081998;139(suppl 53):13\u201316","DOI":"10.1046\/j.1365-2133.1998.1390s3013.x"},{"key":"2021120902384819000_R10","doi-asserted-by":"crossref","unstructured":"Jensen JM, Folster-Holst R, Baranowsky A, et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol.\u20082004;122(6):1423\u20131431","DOI":"10.1111\/j.0022-202X.2004.22621.x"},{"key":"2021120902384819000_R11","doi-asserted-by":"crossref","unstructured":"Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol.\u20082002;119(2):433\u2013439","DOI":"10.1046\/j.1523-1747.2002.01846.x"},{"key":"2021120902384819000_R12","doi-asserted-by":"crossref","unstructured":"Komatsu N, Saijoh K, Kuk C, et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Exp Dermatol.\u20082007;16(6):513\u2013519","DOI":"10.1111\/j.1600-0625.2007.00562.x"},{"key":"2021120902384819000_R13","doi-asserted-by":"crossref","unstructured":"Sandilands A, Terron-Kwiathowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet.\u20082007;39(5):650\u2013654","DOI":"10.1038\/ng2020"},{"key":"2021120902384819000_R14","doi-asserted-by":"crossref","unstructured":"Nomura T, Akiyama M, Sandilands A, et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol.\u20082008;128(6):1436\u20131441","DOI":"10.1038\/sj.jid.5701205"},{"key":"2021120902384819000_R15","doi-asserted-by":"crossref","unstructured":"Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med.\u20082002;347(15):1151\u20131160","DOI":"10.1056\/NEJMoa021481"},{"key":"2021120902384819000_R16","doi-asserted-by":"crossref","unstructured":"Williams JV, Vowels BR, Honig PJ, Leyden JJ. S aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis. Pediatr Dermatol.\u20081998;15(3):194\u2013198","DOI":"10.1046\/j.1525-1470.1998.1998015194.x"},{"key":"2021120902384819000_R17","doi-asserted-by":"crossref","unstructured":"Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol.\u20081988;119(2):189\u2013198","DOI":"10.1111\/j.1365-2133.1988.tb03201.x"},{"key":"2021120902384819000_R18","doi-asserted-by":"crossref","unstructured":"Ravenscroft JC, Layton AM, Eady EA, et al. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol.\u20082003;148(5):1010\u20131017","DOI":"10.1046\/j.1365-2133.2003.05292.x"},{"key":"2021120902384819000_R19","doi-asserted-by":"crossref","unstructured":"Gong JQ, Lin L, Lin T, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol.\u20082006;155(4):680\u2013687","DOI":"10.1111\/j.1365-2133.2006.07410.x"},{"key":"2021120902384819000_R20","doi-asserted-by":"crossref","unstructured":"Hung SH, Lin YT, Chu CY, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol.\u20082007;98(1):51\u201356","DOI":"10.1016\/S1081-1206(10)60859-9"},{"key":"2021120902384819000_R21","doi-asserted-by":"crossref","unstructured":"Brockow K, Grabenhorst P, Abeck D, et al. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema. Dermatology.\u20081999;199(3):231\u2013236","DOI":"10.1159\/000018253"},{"key":"2021120902384819000_R22","doi-asserted-by":"crossref","unstructured":"Wendt C, Schinke S, Wurttemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol.\u20082007;28(9):1036\u20131043","DOI":"10.1086\/519929"},{"key":"2021120902384819000_R23","doi-asserted-by":"crossref","unstructured":"Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol.\u20081992;27(1):29\u201334","DOI":"10.1016\/0190-9622(92)70151-5"},{"key":"2021120902384819000_R24","doi-asserted-by":"crossref","unstructured":"Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol.\u20081994;131(4):536\u2013540","DOI":"10.1111\/j.1365-2133.1994.tb08556.x"},{"key":"2021120902384819000_R25","doi-asserted-by":"crossref","unstructured":"Pournaras CC, Lubbe J, Saurat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J Invest Dermatol.\u20082001;116(3):480\u2013481","DOI":"10.1046\/j.1523-1747.2001.12799.x"},{"key":"2021120902384819000_R26","doi-asserted-by":"crossref","unstructured":"Gauger A, Mempel M, Schekatz A, Shafer T, Ring J, Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology.\u20082003;207(1):15\u201321","DOI":"10.1159\/000070935"},{"key":"2021120902384819000_R27","doi-asserted-by":"crossref","unstructured":"Yoshimura-Mishima M, Akamatsu H, Namura S, Horio T. Suppressive effect of ultraviolet (UVB and PUVA) radiation on superantigen production by Staphylococcus aureus. J Dermatol Sci.\u20081999;19(1):31\u201336","DOI":"10.1016\/S0923-1811(98)00046-2"},{"key":"2021120902384819000_R28","doi-asserted-by":"crossref","unstructured":"Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev.\u20081997;10(4):597\u2013610","DOI":"10.1128\/CMR.10.4.597"},{"key":"2021120902384819000_R29","doi-asserted-by":"crossref","unstructured":"Sassone LM, Fidel RA, Murad CF, Fidel SR, Hirata R Jr. Antimicrobial activity of sodium hypochlorite and chlorhexidine by two different tests. Aust Endod J.\u20082008;34(1):19\u201324","DOI":"10.1111\/j.1747-4477.2007.00071.x"},{"key":"2021120902384819000_R30","doi-asserted-by":"crossref","unstructured":"Wilhelmi BJ, Calianos TA II, Appelt EA, Ortiz ME, Heggers JP, Phillips LG. Modified Dakin's solution for cutaneous vibrio infections. Ann Plast Surg.\u20081999;43(4):386\u2013389","DOI":"10.1097\/00000637-199910000-00007"},{"key":"2021120902384819000_R31","doi-asserted-by":"crossref","unstructured":"Rutala WA, Cole EC, Thomann CA, Weber DJ. Stability and bactericidal activity of chlorine solutions. Infect Control Hosp Epidemiol.\u20081998;19(5):323\u2013327","DOI":"10.1086\/647822"},{"key":"2021120902384819000_R32","doi-asserted-by":"crossref","unstructured":"McKenna PJ, Lehr GS, Leist P, Welling RE. Antiseptic effectiveness with fibroblast preservation. Ann Plast Surg.\u20081991;27(3):265\u2013268","DOI":"10.1097\/00000637-199109000-00011"},{"key":"2021120902384819000_R33","doi-asserted-by":"crossref","unstructured":"Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis.\u20082007;45(5):541\u2013547","DOI":"10.1086\/520663"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/5\/e808\/1103310\/zpe0050900e808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/5\/e808\/1103310\/zpe0050900e808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T09:23:00Z","timestamp":1639041780000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/5\/e808\/71465\/Treatment-of-Staphylococcus-aureus-Colonization-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,1]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-2217","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1159436.620638","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1159436.619802","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}